|
M.B. Antsiferov 1, G.R. Galstyan 2
Administration Of Antidiabetic Drug To Patients – What Is Necessary, Except Prescription?
|
№16 / 2012
|
|
M.B. Antsiferov 1, A.S. Ametov 2, A.V. Zilov 3
Dpp-4 Inhibitors: Today And Tomorrow. What We Expect From Incretin-stimulating Therapy?
|
№7 / 2012
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
|
№3 / 2012
|
|
I.V. Druk, G.I. Nechayeva, O.Yu. Korennova
Sitagliptin: Current Positions And Prospects For Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
|
M.B. Antciferov
Dipeptidyl Peptidase-4 Inhibitors - New Potentials For Treatment Of Type 2 Diabetes Mellitus: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№16 / 2011
|
|
M.B. Antsiferov, L.Yu. Morgunov, N.A. Demidov, I.V. Volokitin
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
|
M.B. Antsiferov, A.V. Zilov
Potentials For Use Of Dipeptidyl Peptidase-4 Inhibitors In Type 2 Diabetes Mellitus: Initiation And Continuation Of Therapy
|
№16 / 2010
|
|
M.Pavlova С. 8790
New Possibilities For Type 2 Diabetes Mellitus Therapy. Results Of A Pilot Observation Program Of Efficacy And Safety Of The Drug «galvus» (vildagliptin) Therapy In Moscow And In The Regions Of The Russian Federation
|
№3 / 2010
|
|
M.B. Anciferov
Innovation Combined Drug Galvus Met (vildagliptin + Metformin) In The Therapy Of Type 2 Diabetes Mellitus.
|
№17 / 2009
|
Русский
